Ataccama
Ataccama Appoints Martin Zahumensky Chief Executive Officer
Ataccama announced a leadership change on August 4, 2026. Ataccama promoted long-time product leader and CTO Martin Zahumensky to CEO as trusted data becomes a gating factor for enterprise AI adoption.
What changed
Martin Zahumensky was named Chief Executive Officer. Mike McKee stepped down after three years as CEO and the launch of Ataccama’s agentic data-trust platform.
- Leader: Martin Zahumensky
- Role: Chief Executive Officer
- Effective: August 4, 2026
- Announcement date: August 4, 2026
Leadership background
Zahumensky has contributed to Ataccama’s product and growth strategy for more than 18 years, most recently as Chief Technology Officer. He helped build and commercialize the company’s earliest data-management solutions across regulated and data-intensive industries.
The mandate
The board selected a product-led CEO to help customers prepare trusted, governed data for enterprise AI and to lead the next phase of the company’s agentic data-trust platform.
Why this matters for GTM teams
Executive appointments can precede changes in strategy, operating cadence, hiring, partnerships, and technology priorities. The useful signal is not the title alone: teams should watch the new leader’s stated mandate, prior playbook, organizational scope, and the initiatives announced during the first two quarters.
Source and methodology
This leadership profile is based on the company’s announcement. Roles, transition timing, and biographical details are presented as announced; SalesTools Research does not infer undisclosed succession plans.
Primary source: Ataccama leadership announcement.
Related Reports
Omnissa Appoints Amit Singh Chief Executive Officer
Omnissa appointed former Palo Alto Networks President Amit Singh CEO to lead AI-powered digital work and agentic endpoint strategy.
MongoDB Appoints Dev Ittycheria Interim CEO
MongoDB appointed former CEO Dev Ittycheria as interim President and CEO after Chirantan “CJ” Desai stepped down to take a senior role at Meta.
Slingshot Biosciences Appoints Dr. Nimisha Srivastava CEO
Slingshot Biosciences promoted Chief Operating Officer Dr. Nimisha Srivastava to CEO to lead commercial growth and product development.
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free